Clinical Trials

54 enrolled

Ovarian Neoplasms

NCT04201561 2023-06-26

SELENIUM

68 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peripheral Nervous System Diseases

NCT00326456 2023-03-27

MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer

820 enrolled

Ovarian Neoplasms

NCT00660842 2023-03-24

MITO-7

800 enrolled

Ovarian Neoplasms, Neurotoxicity Syndromes

NCT01706120 2023-03-24

MITO16/MANGO-2

Phase 4 Unknown

400 enrolled

Ovarian Neoplasms

NCT01802749 2023-03-24

MITO16MANGO2b

406 enrolled

Ovarian Neoplasms

NCT03410784 2023-03-24

MITO28MaNGOov4

72 enrolled

Ovarian Neoplasms

NCT03321188 2023-02-06

Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients

20 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02125513 2022-12-30

GOGER-01

129 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02562365 2022-07-27

ACTS

130 enrolled

Ovarian Neoplasms

NCT05158062 2022-04-26

Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian Cancer

35 enrolled

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00954174 2021-09-30

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

637 enrolled 18 charts

GynecologicSarcoma

Carcinosarcoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04661696 2020-12-10

Efficacy and Safety of Paclitaxel (Albumin-bound) Combination With Carboplatin in Ovarian Cancer.

75 enrolled

Ovarian Neoplasms

NCT04590625 2020-10-19

Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer

58 enrolled

Ovarian Neoplasms

NCT00652119 2020-08-19

Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin

Phase 1 Unknown

46 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03693248 2019-12-10

ROCOCO

298 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01650376 2018-03-23

Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer

52 enrolled

Ovarian Neoplasms, Recurrence, Uterine Neoplasms

NCT03095001 2017-04-13

Intraperitoneal Chemotherapy Alone or in Combination With Bevacizumab for Ovarian Cancer With Peritoneal Adhesion

70 enrolled

Ovarian Neoplasms

NCT00003064 2014-01-06

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer

30 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00003560 2014-01-06

Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

40 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT00002477 2013-12-18

Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00021385 2013-12-18

Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00017303 2013-11-06

Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer

Carcinoma, Ovarian Epithelial, Brenner Tumor, Ovarian Neoplasms

NCT00003733 2013-09-20

Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer

40 enrolled

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00274950 2013-09-17

Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors

CNSGenitourinaryGynecologic

105 enrolled

GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms

NCT00276718 2013-09-17

Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors

Phase NA Unknown

100 enrolled

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms

NCT00838656 2013-09-17

Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

88 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01388621 2013-08-20

PROVE

140 enrolled

Ovarian Neoplasms, Recurrence

NCT00045461 2013-08-07

Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

Phase 2/3 Unknown

241 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00886717 2013-08-02

Paclitaxel-Loaded Polymeric Micelle and Carboplatin as First-Line Therapy in Treating Patients With Advanced Ovarian Cancer

74 enrolled

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT01654146 2012-07-31

ICON8

1,485 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01570582 2012-04-04

A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

314 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00772798 2008-10-15

A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer

70 enrolled

Ovarian Neoplasms

NCT00551577 2007-10-31

PRIMOVAR-1

100 enrolled